Assessment of Immune Response Following Dendritic Cell-Based Immunotherapy in Pediatric Patients With Relapsing Sarcoma

Monocyte-derived dendritic cell (DC)-based vaccines loaded with tumor self-antigens represent a novel approach in anticancer therapy. We evaluated DC-based anticancer immunotherapy (ITx) in an academic Phase I/II clinical trial for children, adolescent, and young adults with progressive, recurrent,...

Descripción completa

Detalles Bibliográficos
Autores principales: Fedorova, Lenka, Mudry, Peter, Pilatova, Katerina, Selingerova, Iveta, Merhautova, Jana, Rehak, Zdenek, Valik, Dalibor, Hlavackova, Eva, Cerna, Dasa, Faberova, Lucie, Mazanek, Pavel, Pavelka, Zdenek, Demlova, Regina, Sterba, Jaroslav, Zdrazilova-Dubska, Lenka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6868036/
https://www.ncbi.nlm.nih.gov/pubmed/31799177
http://dx.doi.org/10.3389/fonc.2019.01169

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6868036/
https://www.ncbi.nlm.nih.gov/pubmed/31799177
http://dx.doi.org/10.3389/fonc.2019.01169

Ejemplares similares